Praxis Precision Medicines (PRAX) Income Statement: Revenue & Earnings

Praxis Precision Medicines Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Praxis Precision Medicines, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	8.55	2.45	0.00	0.00	0.00
Cost of Revenue	152.41	86.77	154.44	0.00	0.00
Gross Profit	-143.86	-84.32	-154.44	0.00	0.00
Operating Expenses
Research & Development	152.41	86.77	155.04	120.26	44.98
Selling, General & Administrative	56.31	42.05	59.55	47.08	16.99
Operating Expenses	56.31	42.05	59.55	167.33	61.97
Operating Income	-200.17	-126.37	-213.99	-167.33	-61.97
Other Income/Expense
Interest Income	17.35	3.14	1.96	2.36	0.14
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	17.35	3.10	0.96	0.27	0.00
Income
Income Before Tax	-182.82	-123.28	-214.03	-167.06	-61.83
Income Tax Expense	0.00	0.00	0.00	0.00	-0.01
Net Income	-182.82	-123.28	-214.03	-167.06	-61.82
Net Income - Continuous Operations	-182.82	-123.28	-214.03	-167.06	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-199.81	-125.94	-213.57	-167.15	-61.92
EBIT	-182.80	-126.37	-213.99	-167.33	-61.97
Depreciation & Amortization	0.36	0.43	0.42	0.18	0.05
Earnings Per Share
Basic EPS	-10.00	-19.00	-70.00	-59.00	-118.00
Diluted EPS	-10.00	-19.00	-70.00	-59.00	-118.00
Basic Shares Outstanding	17.91	6.59	3.07	2.83	0.60
Diluted Shares Outstanding	17.91	6.59	3.07	2.83	0.60